Prospective study on long-term treatment with oxcarbazepine in pediatric epilepsy

Journal of Neurology

Volumn 256, Issue 9, 2009, Pages 1527-1532

  Franzoni, Emilio ^a   Gentile, Valentina ^a   Pellicciari, Alessandro ^a   Garone, Caterina ^a   Iero, Luisa ^a   Gualandi, Stefano ^a   Cordelli, Duccio Maria ^a,b   Cecconi, Ilaria ^a   Moscano, Filomena Caterina ^a   Marchiani, Valentina ^a   Errani, Alessandra ^a  

^a UNIVERSITY OF BOLOGNA   (Italy)

^b UNIVERSITY OF SIENA   (Italy)

Author keywords

Children; Efficacy; Epilepsy; Oxcarbazepine; Tolerability

Indexed keywords

OXCARBAZEPINE;

ADOLESCENT; AGITATION; AMNESIA; ARTICLE; CHILD; CHILDHOOD DISEASE; CLINICAL ARTICLE; CONTROLLED STUDY; DIZZINESS; DRUG BLOOD LEVEL; DRUG DOSE COMPARISON; DRUG EFFICACY; DRUG TOLERABILITY; DRUG WITHDRAWAL; ELECTROENCEPHALOGRAM; EPILEPSY; FATIGUE; FOCAL EPILEPSY; FOLLOW UP; HEADACHE; HUMAN; HYPONATREMIA; LIVER DYSFUNCTION; LONG TERM CARE; PRESCHOOL CHILD; PRIORITY JOURNAL; SCHOOL CHILD; SEDATION; SIDE EFFECT; SYMPTOMATIC EPILEPSY; UNSPECIFIED SIDE EFFECT; WEIGHT GAIN;

ADOLESCENT; ANTICONVULSANTS; BRAIN; CARBAMAZEPINE; CHILD; CHILD, PRESCHOOL; ELECTROENCEPHALOGRAPHY; EPILEPSIES, PARTIAL; FOLLOW-UP STUDIES; HUMANS; PROSPECTIVE STUDIES; TIME FACTORS; TREATMENT OUTCOME;

EID: 69549124002     PISSN: 03405354     EISSN: 14321459     Source Type: Journal    
DOI: 10.1007/s00415-009-5157-8     Document Type: Article

References (28)

1. JA Armijio N Vega-Gin M Shushtarian J Adìn JL Herranz 2005 10-hydroxycarbazepine serum concentration-to-oxcarbazepine dose ratio: influence of age and concomitant antiepileptic drugs Ther Drug Monit 27 2 199 204 10.1097/01.ftd.0000155342.93489.fd (Pubitemid 40463649)
2. A Cukiert R Sachdeo R Ayala 2004 A multicenter, rater-blind, randomized, age-stratified, parallel-group study comparing high- versus low-dose oxcarbazepine monotherapy in pediatric patients with inadequately controlled partial seizures Epilepsia 45 Suppl 7 318
3. M Dam R Ekberg Y Loyning O Waltimo K Jakobsen 1989 A double-blind study comparing oxcarbazepine and carbazepine in patients with newly diagnosed, previously untreated epilepsy Epilepsy Res 3 70 76 10.1016/0920-1211(89)90070-3 (Pubitemid 19009372)
4. F Donati G Gobbi J Campistol G Rapatz M Daehler Y Sturm AP Aldenkamp 2007 The cognitive effects of oxcarbazepine versus carbamazepine or valproate in newly diagnosed children with partial seizures Seizure 16 670 679 10.1016/j.seizure.2007.05.006 (Pubitemid 350027187)
5. E Franzoni C Garone J Sarajlija S Gualandi E Malaspina I Cecconi FC Moscano V Marchiani 2006 Open prospective study on oxcarbazepine in epilepsy in children: a preliminary report Seizure 15 292 298 10.1016/j.seizure.2006.02.017 (Pubitemid 43812240)
6. JA French AM Kanner J Bautista, et al. 2004 Efficacy and tolerability of the new antiepileptic drugs, I: treatment of new onset epilepsy Neurology 62 1252 1260
7. JA French AM Kanner J Bautista, et al. 2004 Efficacy and tolerability of the new antiepileptic drugs, II: treatment of refractory epilepsy: report of the TTA and QSS subcommittees of the American Academy of Neurology and the American Epilepsy Society Epilepsia 49 5 410 423 10.1111/j.0013-9580.2004.06304.x (Pubitemid 38581554)
8. DM Gazzola JA French 2008 Clinical trials in epilepsy: the SANAD study Rev Neurol Dis 5 1 36 37
9. TA Glauser M Nigro RC Sachdeo, et al. 2000 Adjunctive therapy with oxcarbazepine in children with partial seizures Neurology 54 12 2237 2244
10. DF Gonzalez-Esquivel M Ortega-Gavilan G Alcantara-Lopez H Jung-Cook 2000 Plasma level monitoring of oxcarbazepine in epileptic patients Arch Med Res 31 202 205 10.1016/S0188-4409(00)00056-4 (Pubitemid 30392359)
11. S Grosso M Balestri RM Di Bartolo L Corbini G Vatti P Curatolo P Balestri 2006 Oxcarbazepine and atypical evolution of benign idiopathic focal epilepsy of childhood Eur J Neurol 13 1142 1145 10.1111/j.1468-1331.2006.01464.x (Pubitemid 44434322)
12. Y Hamada T Okuno H Hattori H Mikawa 1994 Indication for anti-epileptic drug treatment of benign childhood epilepsy with centro-temporal spikes Brain Dev 16 2 159 161 10.1016/0387-7604(94)90056-6 (Pubitemid 24114116)
13. J Hengel 2001 A proposed diagnostic scheme for people with epileptic seizures and with epilepsy: report of the ILAE task force on classification and terminology Epilepsia 42 6 796 803 10.1046/j.1528-1157.2001.10401.x (Pubitemid 32605946)
14. M Holtmann M Krause J Opp M Tokarzewski E Korn-Merker HE Boenigk 2002 Oxcarbazepine-induced hyponatremia and the regulation of serum sodium after replacing carbamazepine with oxcarbazepine in children Neuropediatrics 33 6 298 300 10.1055/s-2002-37081 (Pubitemid 36222141)
15. JF de la Horga Parte A Horga 2006 Oxcarbazepine in the treatment of epilepsy. A review and update Rev Neurol 42 2 95 113
16. MM Kalis NA Huff 2001 Oxcarbazepine, an antiepileptic agent Clin Ther 23 680 700 10.1016/S0149-2918(01)80019-9 (Pubitemid 32472601)
17. SV Kothare DS Khurana N Mostofi JJ Melvin HG Marks I Valencia A Legido 2006 Oxcarbazepine monotherapy in children and adolescents: a single-center clinical experience Pediatr Neurol 35 4 235 239 10.1016/j.pediatrneurol.2006.02. 009 (Pubitemid 44397424)
18. N Marchi G Guiso M Rizzi S Pirker K Novak T Czech C Baumgartner D Janigro S Caccia A Vezzani 2005 A pilot study on brain-to-plasma partition of 10, 11-Dyhydro-10-hydroxy-5H-dibenzo(b, f)azepine-5-carboxamide and MDR1 brain expression in epilepsy patients not responding to oxcarbazepine Epilepsia 46 10 1613 1620 10.1111/j.1528-1167.2005.00265.x (Pubitemid 44921935)
19. MV Miles PH Tang MA Ryan SA Grim TA Fakhoury RH Strawsburg TJ DeGrauw RJ Baumann 2004 Feasibility and limitations of oxcarbazepine monitorin using salivary monohydroxycarbamazepine (MHD) Ther Drug Monit 26 3 300 304 10.1097/00007691-200406000-00014 (Pubitemid 38703018)
20. M Muller AG Marson PR Williamson 2006 Oxcarbazepine versus phenytoin monotherapy for epilepsy Cochrane Database Syst Rev 2 1 8 Review
21. JM Pellock 2002 Tricyclic anticonvulsants: safety and adverse effects Epilepsy Behav 3 S19 S23 10.1016/S1525-5050(02)00538-3
22. E Perucca 2002 Clinical pharmacology and therapeutic use of the new antiepileptic drugs Fundam Clin Pharmacol 15 6 405 417 10.1046/j.1472-8206.2001. 00055.x Review. Erratum in: Fundam Clin Pharmacol
23. JE Piña-Garza R Espinoza D Nordli, et al. 2005 Oxcarbazepine adjunctive therapy in infants and young children with partial seizures Neurology 65 1370 1375 10.1212/01.wnl.0000186800.18456.72 (Pubitemid 41552763)
24. (1989) Proposal for revised classification of epilepsies and epileptic syndromes. Commission on classification and terminology ofthe international against epilepsy. Epilepsia 30:389-399. doi: 10.1111/j.1528-1157.1989.tb05316.x
25. GP Raju DP Sarco A Poduri JJ Riviello AMR Bergin M Takeoka 2007 Oxcarbazepine in children with nocturnal frontal-lobe epilepsy Pediatr Neurol 37 345 349 10.1016/j.pediatrneurol.2007.06.013 (Pubitemid 47575826)
26. M Tzitiridou T Panou G Ramantani A Kambas K Spyroglou C Panteliadis 2005 Oxcarbazepine monotherapy in benign childhood epilepsy with centrotemporal spikes: a clinical and cognitive evaluation Epilepsy Behav 7 3 458 467 10.1016/j.yebeh.2005.07.012 (Pubitemid 41614141)
27. M Vendrame DS Khurana M Cruz J Melvin I Valencia A Legido SV Kothare 2007 Aggravation of seizures and/or EEG features in children treated with oxcarbazepine monotherapy Epilepsia 48 11 2116 2120 10.1111/j.1528-1167.2007. 01210.x (Pubitemid 350098758)
28. A Verrotti G Coppola R Manco G Ciambra P Iannetti S Grosso P Balestri E Franzoni F Chiarelli 2007 Levetiracetam monotherapy for children and adolescents with benign rolandic seizures Seizure 16 3 271 275 10.1016/j.seizure.2006.12. 006 (Pubitemid 46336818)